*Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai

†Department of Medicine, NewYork Presbyterian – Columbia University Irving Medical Center

∥Icahn School of Medicine at Mount Sinai, Tisch Cancer Center, New York, NY

‡Department of Medical Education, Rutgers New Jersey Medical School, Newark, NJ

§Prostate Cancer Foundation, Santa Monica, CA

¶Arvinas Inc., New Haven, CT

Z.C. and G.M. are co-first authors and contributed equally.

G.M., V.G.P., and Z.C.: study conception and design;. G.M., Z.C., N.S., S.M., and N.T.: data collection and management; G.M. and Z.C.: data analysis and interpretation.

V.G.P. is a full-time employee of Arvinas. He has received consulting fees from Seagen and Sanofi Genzyme. The other authors declare no conflicts of interest.

Correspondence: Vaibhav G. Patel, MD, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Library Pl, Box 1128, New York, NY 10029. E-mail: [email protected].